Uganda

in page functions
[French]
Uganda
Total population (2017) 41,652,849
Birth cohort (2017) 1,738,263
Surviving Infants (surviving to 1 year per year, 2017) 1,640,397
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 38/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 55/1000
World Bank Index, IDA (2015) 3.74
Gross Nation Income (per capita US$, 2015) 700
Co-financing group (2018) Initial self-financing
No. of districts/territories (2016) 112

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Uganda

Type of support

Approvals

2001-2022 (US$)
(29 May 2018)

Commitments

2001-2022 (US$)
(29 May 2018)

Disbursements

2000-2018 (US$)
(29 May 2018)

% Disbursed

(29 May 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $378,511,158 $464,228,658 $339,104,455
Cold Chain Equipment Optimisation Platform (CCEOP) $6,648,068 $6,648,068 $1,994,722 30%
Health system strengthening (HSS 1) $19,242,000 $19,242,000 $16,421,701 85%
Health system strengthening (HSS 2) $13,110,000 $30,600,000 $608,796 5%
HPV (NVS) $18,567,521 $28,557,521 $16,729,021 90%
Immunisation services support (ISS) $9,230,520 $9,230,520 $9,230,520 100%
Injection Safety Devices (NVS) $1,141,500 $2,286,500 $1,486,786 130%
Injection safety support (INS) $1,207,299 $1,207,299 $1,207,299 100%
IPV (NVS) $8,716,415 $8,716,415 $5,566,889 64%
Measles (NVS) $85,500 $85,500 $97,370 114%
Measles-Catch-up campaign (NVS) $109,500 $109,500
Meningitis A - campaign (NVS) $5,538,937 $5,538,937 $5,538,937 100%
Meningitis A - operational costs (OPC) $4,552,647 $4,552,647 $4,366,265 96%
Operational costs (OPC) $349,355 $349,355
Penta (NVS) $171,444,366 $177,338,366 $169,656,739 99%
Penta - campaign (NVS) $765,000 $765,000
Pneumo (NVS) $100,357,497 $138,183,997 $96,104,827 96%
Pneumo - campaign (NVS) $3,287,000 $3,287,000
Product Switch Grant (PSG) $470,533 $470,533
Rotavirus (NVS) $8,015,500 $21,387,500 $4,422,583 55%
Vaccine Introduction Grant (VIG) $5,672,000 $5,672,000 $5,672,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Uganda DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 93%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2010) 72.00%
Household survey: DTP3 coverage for female (2010) 71.00%
Household survey: Last DTP3 survey (2010) 72%
% districts achieving > 80% DTP3 coverage (2016) 90%
% districts achieving < 50% DTP3 coverage (2016) 0%
MCV WHO/UNICEF estimates (2016) 82%

Breakdown of support

Non-vaccine support Vaccine support
12% 88%
$39,501,303 $299,603,152

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Uganda

07 May 2018

Zambian children

Largest cholera vaccine drive in history to target spike in outbreaks

Two million people in five African countries to be protected against cholera.

25 January 2018

Tanzania fridge 2014

WEF-Davos 2018: Gavi announces new private-sector partnerships

New partnerships announced by Gavi at WEF-Davos 2018 demonstrate the critical role of private sector expertise in helping developing countries increase immunisation coverage. Learn more about how and where the partnerships will make a difference.

08 December 2016

Syrian children

Gavi to support immunisation of children in Syria

Gavi Board decisions also taken to strengthen emergency vaccine stockpiles and to accelerate human papillomavirus (HPV) vaccine programme to protect 40 million girls against cervical cancer by 2020.

close icon

modal window here